ARTICLE | Top Story
AiCuris, Merck in CMV deal
October 16, 2012 1:33 AM UTC
AiCuris GmbH & Co. KG (Wuppertal, Germany) granted Merck & Co. Inc. (NYSE:MRK) exclusive, worldwide rights to its human cytomegalovirus (CMV) portfolio, including letermovir ( AIC246). Earlier this ye...